Efficacy and safety of GSK3772847 in participants with moderate-to-severe asthma with allergic fungal airway disease: A phase IIa randomized, multicenter, double-blind, sponsor-open, comparative trial

• Chika Akinseye ,

  Roles Conceptualization, Formal analysis, Writing – review & editing

  * E-mail: chika.u.ogueri@gsk.com

  Affiliation Medicines Research Centre, GSK, Stevenage, Hertfordshire, United Kingdom

  https://orcid.org/0000-0003-3888-3710

  ⨯
• Courtney Crim,

  Roles Conceptualization, Formal analysis, Writing – review & editing

  Affiliation Clinical Sciences–Respiratory, GSK, Research Triangle Park, North Carolina, United States of America

  ⨯
• Amy Newlands,

  Roles Conceptualization, Formal analysis, Writing – review & editing

  Affiliation Respiratory Medicines Development Centre, GSK, Brentford, Middlesex, United Kingdom

  ⨯
• David Fairman

  Roles Conceptualization, Formal analysis, Writing – review & editing

  Affiliation Clinical Pharmacology Modelling and Simulation, GSK, Stevenage, Hertfordshire, United Kingdom

  https://orcid.org/0000-0002-7756-0212

  ⨯